Clinical Investigative Site # 3135 — Newark, New Jersey

Clinical Investigative Site # 3135 is a clinical research site located in Newark, New Jersey, United States 07103.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Investigative Site # 3135 has participated in 1 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Investigative Site # 3135?

Clinical Investigative Site # 3135 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Investigative Site # 3135 conducted?

Clinical Investigative Site # 3135 has 1 clinical trials on record. Their work covers Multiple Sclerosis.

Is Clinical Investigative Site # 3135 accredited by Crixeo Health?

Clinical Investigative Site # 3135 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Investigative Site # 3135?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.